Oligomerix, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2006-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.oligomerix.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Phase 1 Study of OLX-07010 in Healthy Adult and Elderly Participants
Phase 1
- Conditions
- Alzheimer Disease
- Interventions
- Drug: OLX-07010 ActiveDrug: OLX-07010 Placebo
- First Posted Date
- 2023-01-25
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Oligomerix, Inc
- Target Recruit Count
- 88
- Registration Number
- NCT05696483
- Locations
- 🇺🇸
California Clinical Trials Medical Group, Inc, Glendale, California, United States
News
No news found